ARTA
ENZY

A.R.T. Advisors’s Enzymotec Ltd ENZY Stock Holding History

A.R.T. Advisors’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,569
Closed -$113K – 1837
2015
Q4 		$113K Buy
+11,569
New +$110K 0.01% 1313
2014
Q4 		– Sell
-28,039
Closed -$187K – 1813
2014
Q3 		$187K Buy
28,039
+5,766
+26% +$62.2K 0.01% 1120
2014
Q2 		$302K Buy
+22,273
New +$374K 0.02% 986

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's ENZY Position: Q1 2016 in Review

A.R.T. Advisors sold out of Enzymotec Ltd (ENZY) in Q1 2016, closing a stake of 11,569 shares — an estimated $113K sold.

A.R.T. Advisors first reported a position in ENZY in Q2 2014 and held it in 3 quarters. The position peaked at $302K in Q2 2014. 30 funds tracked by Wall St. Rank hold ENZY as of Q1 2016.

  • A.R.T. Advisors reported no remaining Enzymotec Ltd position as of Q1 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 11,569 Enzymotec Ltd shares in Q1 2016, an estimated $113K.
  • A.R.T. Advisors first reported a position in Enzymotec Ltd in Q2 2014 and held it in 3 quarters.
  • A.R.T. Advisors's Enzymotec Ltd position peaked at $302K in Q2 2014.
  • 30 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2016.

Based on A.R.T. Advisors's 13F filing for Q1 2016, filed 16 May 2016.